Keyword Suggestion
Domain Informations
Retevmo.com lookup results from whois.brandsight.com server:
- Domain created: 2019-02-14T19:47:27Z
- Domain updated: 2024-01-17T23:03:09Z
- Domain expires: 2025-02-14T19:47:27Z 0 Years, 100 Days left
- Website age: 5 Years, 264 Days
- Registrar Domain ID: 2360876538_DOMAIN_COM-VRSN
- Registrar Url: http://gcd.com
- Registrar WHOIS Server: whois.brandsight.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.5189669187
- Name server:
- A1-33.AKAM.NET
- A11-64.AKAM.NET
- A2-65.AKAM.NET
- A22-66.AKAM.NET
- A7-67.AKAM.NET
- A8-64.AKAM.NET
Network
- inetnum : 13.244.0.0 - 13.251.255.255
- name : AT-88-Z
- handle : NET-13-244-0-0-1
- status : Direct Allocation
- created : 2011-12-08
- changed : 2024-01-24
- desc : All abuse reports MUST include:,* src IP,* dest IP (your IP),* dest port,* Accurate date/timestamp and timezone of activity,* Intensity/frequency (short log extracts),* Your contact details (phone and email) Without these we will be unable to identify the correct owner of the IP address at that point in time.
Owner
- organization : Amazon Technologies Inc.
- handle : AT-88-Z
- address : Array,Seattle,WA,98109,US
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 13.248.144.105
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Timezone: America/Los_Angeles
Site Inspections
Port Scanner (IP: 13.248.144.105)
Spam Check (IP: 13.248.144.105)
Recent Searched Sites
› Konfiskat-gov.ru (1 seconds ago) / US
› Desempacados.com (22 seconds ago) / US
› Cryptominerbros.com (10 seconds ago) / US
› Comunesbt.it (19 seconds ago) / IT
› Iesparquesol.centros.educa.jcyl.es (15 seconds ago) / ES
› Wrotik.com (26 seconds ago) / RU
› Industrialchemicals.gov.au (13 seconds ago) / AU
› Freeb.tc (24 seconds ago) / TR
› Pemptousia.gr (26 seconds ago) / US
› Retevmo.com (0 seconds ago) / US
› Westergaard-mays-2.technetbloggers.de (8 seconds ago) / US
› My.uzedu.uz (4 seconds ago) / UZ
› Cultura.hu (20 seconds ago) / HU
› Dbm.yju.ac.kr (5 seconds ago) / KR
› Borsedubai.ae (28 seconds ago) / AE
› Autolocksmiths74202.pointblog.net (9 seconds ago) / US
› Qestigra.ucoz.ru (25 seconds ago) / RU
› Bluefoot.com.br (5 seconds ago) / US
› Billjonessucks.com (9 seconds ago) / US
› Helzle.it (20 seconds ago) / DE
Websites Listing
We found Websites Listing below when search with retevmo.com on Search Engine
Retevmo® (selpercatinib) | RET-positive (RET+) Thyroid
Retevmo is an oral targeted therapy you can take at home. With Retevmo, it's time to reimagine tomorrow. The first FDA-approved treatment for people with RET-positive metastatic non-small …
Retevmo.comSavings & Support: Savings Card & More | Retevmo® …
Requesting a Retevmo savings card shouldn’t take more than a few minutes. If you do not want to provide HIPAA authorization online, please contact the Lilly Oncology Support Center at 1 …
Retevmo.com医療関係者向け|レットヴィモ ® (セルペルカチニブ) …
医療関係者向け|レットヴィモ ® (セルペルカチニブ)-Lillymedical.jp. チャットボットで問い合わせる. 当社製品の副作用・不具合に関わると思われる事項につきましては、必ずお電話 ( …
Lillymedical.jpselpercatinib | CADTH
CADTH review report (s) and responses to comments provided to sponsor. 25-Feb-22. Expert committee meeting (initial) 09-Mar-22. Draft recommendation issued to sponsor. 22-Mar-22. …
Cadth.caLilly Presents New Data on Retevmo ... - Eli Lilly and Company
2021-04-11 · About Retevmo ® (selpercatinib) Retevmo (selpercatinib, formerly known as LOXO-292) (pronounced reh-TEHV-moh) is a selective and potent RET kinase inhibitor. …
Investor.lilly.comRetevmo Coupon & Prices - Cost $49 per month - NiceRx
Retevmo costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Retevmo oral capsule 80 mg will typically cost around $10,800 for 60 …
Nicerx.comRetevmo oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
Retevmo 80 Mg Capsule Antineoplastic - Protein-Tyrosine Kinase Inhibitors - Uses, Side Effects, and More Generic Name: selpercatinib . This medication is used to treat certain types of …
Webmd.com[Product Monograph Template - Standard]
RETEVMO™ Selpercatinib Page 5 of 52 PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS RETEVMO (selpercatinib) is indicated as monotherapy for the treatment of: • …
Pdf.hres.caOncology - Retevmo PA Policy
PRIOR AUTHORIZATION POLICY POLICY: Oncology –Retevmo Prior Authorization Policy ™Retevmo (selpercatinib capsules Eli Lilly) REVIEW DATE: 06/01/2022 OVERVIEW …
D11tr245s7jfj6.cloudfront.netLilly Presents Updated Data on Retevmo® (selpercatinib) in …
2022-04-01 · Retevmo (selpercatinib, formerly known as LOXO-292) (pronounced ret- tév-mo) is a selective and potent RET kinase inhibitor. Retevmo may affect both tumor cells and healthy …
Prnewswire.comRetevmo (selpercatinib) dosing, indications, interactions, adverse ...
Idelalisib will increase the level or effect of selpercatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. If coadministration necessary, reduce …
Reference.medscape.comRetevmo Side Effects: What They Are and How to Manage Them
2022-06-09 · lower level of albumin, a protein that moves various substances throughout the body. swelling of the arms or legs. constipation. low sodium or calcium level in the blood. …
Healthline.comRetevmo™ (selpercatinib) - Prior Authorization/Notification ...
Retevmo will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Retevmo therapy . Authorization will be issued for 12 months. E. …
Uhcprovider.comDailyMed - RETEVMO- selpercatinib capsule
2022-04-22 · RETEVMO (selpercatinib) is supplied as 40 mg or 80 mg hard gelatin capsules for oral use. Each capsule contains inactive ingredients of microcrystalline cellulose and colloidal …
Dailymed.nlm.nih.govLilly Receives U.S. FDA Approval for Retevmo ... - Insider
2020-05-08 · About Retevmo™ (selpercatinib) Retevmo (selpercatinib, formerly known as LOXO-292) (pronounced reh-TEHV-moh) is a selective and potent RET kinase inhibitor. …
Markets.businessinsider.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
bistrochat.com | godaddy.com | -1 Years, -273 Days |
xytex.com | networksolutions.com | 354 Days |
pure1.org | ionos.com | -2 Years, -31 Days |
smarttraderiq.com | fastdomain.com | 55 Days |
incite-tech.com | infomaniak.com | -2 Years, -138 Days |
dulinks.in | openprovider.com | -2 Years, -32 Days |
rinnaichinhhang.com | pavietnam.vn | -1 Years, -30 Days |
lovee.cc | namecheap.com | -1 Years, -346 Days |
myjam.com | uniregistry.com | 1 Year, 217 Days |
rrxz.net | net.cn | -1 Years, -308 Days |